Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
5.61
+0.61 (12.20%)
At close: Dec 20, 2024, 4:00 PM
5.54
-0.07 (-1.25%)
After-hours: Dec 20, 2024, 7:50 PM EST
Sage Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 343 | 1,301 | 2,269 | 2,506 | 4,502 | 3,741 | |
| Market Cap Growth | -64.23% | -42.67% | -9.45% | -44.34% | 20.36% | -16.71% | |
| Enterprise Value | -216 | 432 | 889 | 683 | 3,864 | 2,657 | |
| Last Close Price | 5.61 | 21.67 | 38.14 | 42.54 | 86.51 | 72.19 | |
| PE Ratio | - | - | - | - | 7.43 | - | |
| PS Ratio | 3.19 | 15.05 | 295.22 | 397.27 | 4.04 | 544.66 | |
| PB Ratio | 0.62 | 1.63 | 1.81 | 1.45 | 2.17 | 3.96 | |
| P/TBV Ratio | 0.80 | 1.63 | 1.81 | 1.45 | 2.17 | 3.96 | |
| P/FCF Ratio | - | - | - | - | 6.78 | - | |
| P/OCF Ratio | - | - | - | - | 6.78 | - | |
| EV/Sales Ratio | - | 4.99 | 115.69 | 108.23 | 3.47 | 386.92 | |
| EV/EBITDA Ratio | - | - | - | - | 6.17 | - | |
| EV/EBIT Ratio | - | - | - | - | 6.19 | - | |
| EV/FCF Ratio | - | - | - | - | 5.82 | - | |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | |
| Debt / EBITDA Ratio | - | - | - | - | 0.04 | - | |
| Debt / FCF Ratio | - | - | - | - | 0.04 | - | |
| Asset Turnover | 0.14 | 0.08 | 0.00 | 0.00 | 0.69 | 0.01 | |
| Inventory Turnover | - | 224.00 | 210.95 | - | - | - | |
| Quick Ratio | 9.72 | 10.12 | 12.97 | 20.68 | 31.24 | 8.99 | |
| Current Ratio | 10.02 | 10.51 | 13.47 | 21.14 | 31.58 | 9.23 | |
| Return on Equity (ROE) | -49.34% | -52.77% | -35.74% | -24.09% | 40.18% | -75.26% | |
| Return on Assets (ROA) | -29.62% | -30.51% | -21.49% | -14.46% | 24.05% | -43.46% | |
| Return on Capital (ROIC) | -33.60% | -33.01% | -22.70% | -14.97% | 25.31% | -47.98% | |
| Earnings Yield | -98.37% | -41.62% | -23.48% | -18.27% | 13.46% | -18.18% | |
| FCF Yield | -93.26% | -41.60% | -20.32% | -15.11% | 14.75% | -14.29% | |
| Buyback Yield / Dilution | -1.23% | -0.89% | -1.08% | -10.69% | -4.27% | -10.22% | |
| Total Shareholder Return | -1.23% | -0.89% | -1.08% | -10.69% | -4.27% | -10.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.